Moderna to ask health regulators to authorize its COVID-19 vaccine — The Wall Street Journal
Moderna will ask U.S. and European health regulators today to authorize use of its Covid-19 vaccine after it was shown to be 94.1% effective in a full analysis of a pivotal study, keeping it on track to go into use in the U.S. by the end of the year, alongside the Pfizer and BioNTech vaccine.